UseGrants

DoW Breast Cancer, Breakthrough Award Level 4

Defense Health Agency Contracting Activity - DHACAAmount not specifiedDue Sep 30, 2026
View & apply on Grants.gov →

This Department of War (Defense Health Agency) Breast Cancer Research Program Breakthrough Award Level 4 supports promising research with high potential for breakthroughs in breast cancer. Eligibil…

Deadline
Sep 30, 2026
Posted
May 4, 2026
Award amount
Amount not specified
Focus areas
Science and Technology and other Research and Development

Don’t miss this deadline

We’ll email you before Sep 30, 2026 so you have time to apply.

In plain English

This Department of War (Defense Health Agency) Breast Cancer Research Program Breakthrough Award Level 4 supports promising research with high potential for breakthroughs in breast cancer. Eligibility is described as unrestricted (open to any entity type), subject to clarifications. Clinical trials are required for this level, and the research team must include two or more breast cancer consumer advocates. Up to two partnering Principal Investigators are allowed. No specific award amount is stated; applications must address an FY26 BCRP overarching challenge.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

About this grant

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Level 4. Distinctive Features: · Clinical trials are required. · The research team must include two or more breast cancer consumer advocates. · This funding mechanism allows for a single Principal Investigator (PI), or two partnering PIs referred to as the Initiating PI and the Partnering PI. For the Partnering PI Option (PPIO), only the Initiating PI will submit a pre-application, but both PIs will need to submit at the full application stage. Be advised, failure to submit all associated (Initiating and Partnering PI) applications by the deadline may result in administrative withdrawal.

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit

Related grants

Other open grants funding Science and Technology and other Research and Development — soonest deadline first.

Also listed under Defense Health Agency Contracting Activity - DHACA and Science & Research Grants.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.